Par Pharmaceutical, Inc.
Six Ram Ridge Road
Chestnut Ridge
New York
10977
United States
Tel: 800-727-0923
Fax: 845-425-7167
Website: http://www.parpharm.com/
151 articles about Par Pharmaceutical, Inc.
-
Par Pharmaceutical, Inc. Announces Quarterly Conference Call
5/9/2013
-
Par Pharmaceutical, Inc. to Pay $45 Million to Resolve Criminal, Civil Charges
3/7/2013
-
Par Pharmaceutical, Inc. Begins Shipment of Rizatriptan Benzoate Tablets and Rizatriptan Benzoate Orally Disintegrating Tablets
1/3/2013
-
Par Pharmaceutical, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation of Acquisition by TPG
7/16/2012
-
GlaxoSmithKline Partner Pronova BioPharma Wins Lovaza Patent Case Against Teva Pharmaceutical Industries Limited & Par Pharmaceutical, Inc.
5/31/2012
-
Activist Investor Pushes Par Pharmaceutical, Inc. to Consider Selling Itself
5/9/2012
-
Par Pharmaceutical, Inc. Begins Shipment of Generic Provigil®
4/6/2012
-
Horizon Pharma, Inc. Files Patent Infringement Lawsuit Against Par Pharmaceutical, Inc. for Filing an ANDA Against DUEXIS(R)
3/29/2012
-
Par Pharmaceutical, Inc. Completes Acquisition of Edict Pharmaceuticals
2/21/2012
-
IntelGenx Corp. Announces Development and Commercialization Agreement With Par Pharmaceutical, Inc.
12/21/2011
-
Par Pharmaceutical, Inc. Begins Shipment of Generic Zyprexa(R) Zydis(R)
10/25/2011
-
Par Pharmaceutical, Inc. Acquires Three Generic Products From TEVA Pharmaceuticals USA
10/18/2011
-
Par Pharmaceutical, Inc. Files Declaratory Judgment to Protect First Amendment Rights to Disseminate Truthful Information Regarding Megace(R) ES
10/17/2011
-
Par Pharmaceutical, Inc. Companies to Report Third Quarter 2011 Results on November 2, 2011
10/4/2011
-
IntelliPharmaCeutics and Par Pharmaceutical, Inc. Expand Development and Commercialization Agreement
8/18/2011
-
AVANIR Pharmaceuticals Files Lawsuits Against Par Pharmaceutical, Inc. and Actavis for Infringement of NUEDEXTA Patents
8/11/2011
-
Par Pharmaceutical, Inc. Slashes100 Jobs
6/30/2011
-
Par Pharmaceutical, Inc. to Acquire Edict Pharmaceuticals for up to $37.6 Million in Cash
5/23/2011
-
Pozen, Inc. Gets Court Relief on Migraine Drug vs Par Pharmaceutical, Inc.
4/15/2011
-
Par Pharmaceutical, Inc. Begins Shipment of Generic Rythmol SR(R)
1/4/2011